Royalty Pharma plc

Healthcare

NASDAQ:RPRX · NASDAQ Global Select

Market Cap $23.45B Beta 0.42 P/E (TTM) 28.8

$54.87 -0.24%

-$0.14 today

52W Low $34.08High $56.50

Vol 3.07M · Avg 3.65M

EPS (TTM)$1.92

Div Yield1.65%

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+60.91%

Period High

$55.87

Period Low

$33.83

Latest

$54.87

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

United Therapeutics Corporation

NASDAQ:UTHR

$23.00B

Roivant Sciences Ltd.

NASDAQ:ROIV

$21.79B

Incyte Corporation

NASDAQ:INCY

$21.78B

Hologic, Inc.

HOLX

$16.97B

Genmab A/S

NASDAQ:GMAB

$15.37B

Tenet Healthcare Corporation

NYSE:THC

$15.26B

Exelixis, Inc.

NASDAQ:EXEL

$13.39B

Smith & Nephew plc

NYSE:SNN

$12.97B

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

$12.36B

Summit Therapeutics Inc.

NASDAQ:SMMT

$10.59B

What is the latest RPRX filing?

The latest filing shown is 4 dated Jun 8, 2026.

How many recent filings does RPRX have?

Intrinsic Alpha currently shows 20 recent filings for RPRX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.